Loading…

Anti-amyloidogenic effects of soybean isoflavones in vitro: Fluorescence spectroscopy demonstrating direct binding to Aβ monomers, oligomers and fibrils

Alzheimer's disease is characterized by the presence of extracellular deposits of amyloid, primarily composed of the amyloid β-protein (Aβ). A growing body of evidence indicates that oligomeric forms of Aβ play a critical role in disease causation. Soybean isoflavones are flavonoids with an iso...

Full description

Saved in:
Bibliographic Details
Published in:Biochimica et biophysica acta 2012-08, Vol.1822 (8), p.1316-1324
Main Authors: Hirohata, Mie, Ono, Kenjiro, Takasaki, Jun-ichi, Takahashi, Ryoichi, Ikeda, Tokuhei, Morinaga, Akiyoshi, Yamada, Masahito
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Alzheimer's disease is characterized by the presence of extracellular deposits of amyloid, primarily composed of the amyloid β-protein (Aβ). A growing body of evidence indicates that oligomeric forms of Aβ play a critical role in disease causation. Soybean isoflavones are flavonoids with an isoflavone backbone. Isoflavones have been reported to protect against Aβ-induced neurotoxicity in cultured cell systems, the molecular mechanisms remain unclear. Our previous studies demonstrated that red wine-related flavonoids with a flavone backbone are able to inhibit Aβ assembly and destabilize preformed Aβ aggregates. Here, we show that isoflavones, especially glycitein and genistein, have anti-fibrillization, anti-oligomerization and fibril-destabilizing effects on Aβ1–40 and Aβ1–42in vitro at physiological pH and temperature, by using nucleation-dependent polymerization monitored by thioflavin T fluorescence, atomic force microscopy, electron microscopy, and photo-induced cross-linking of unmodified proteins followed by SDS-PAGE. Our three-dimensional fluorescence spectroscopic analyses demonstrated that glycitein interacted with Aβ monomers, oligomers and fibrils, indicating specific binding of glycitein to these Aβ species. Glycitein also interacted with different Aβ fragments (Aβ1–42, Aβ1–40, Aβ1–16 and Aβ25–35), exhibiting the highest fluorescence enhancement with Aβ25–35. We speculated that glycitein's anti-amyloidogenic properties are specifically mediated by its binding to Aβ monomers, oligomers and fibrils. Isoflavones may hold promise as a treatment option for preventative strategies targeting amyloid formation in Alzheimer's disease. ► Isoflavones inhibited the fibrillization and oligomerization of amyloid β-proteins (Aβs). ► Isoflavones destabilized preformed amyloid β-protein (Aβ) fibrils. ► Glycitein bound to Aβ monomers, oligomers and fibrils, leading the anti-amyloidogenic effects. ► Glycitein bound to Aβ1–42, Aβ1–40, Aβ1–16 and Aβ25–35, having the most potent affinity for Aβ25–35.
ISSN:0925-4439
0006-3002
1879-260X
DOI:10.1016/j.bbadis.2012.05.006